Literature DB >> 28242093

[Acute generalized exanthematous pustulosis induced by phloroglucinol].

N Brahimi1, E Maubec2, T Petit3, B Crickx4, V Descamps4.   

Abstract

BACKGROUND: Acute generalized exanthematous pustulosis (AGEP) is a severe drug eruption. We report herein the first case of AGEP induced by phloroglucinol (Spasfon®). PATIENTS AND METHODS: A 27-year-old pregnant woman developed a febrile exanthematous pustulosis eruption three days after treatment with intravenous phloroglucinol and paracetamol for nephritic colic. She had no previous history of psoriasis. The laboratory workup showed hyperleukocytosis with neutrophilia. A cytobacteriological sample of the pustules was negative. Skin biopsy revealed marked neutrophilic and leukocytoclastic vasculitis. Reintroduction of phloroglucinol after delivery resulted in the same clinical symptoms within a few hours of intake. A diagnosis of phloroglucinol-induced AGEP was made on the basis of intrinsic imputability of I4 (S3 C3) using the imputability criteria of Begaud et al. The outcome was favorable after withdrawal of the drug. DISCUSSION: To the best of our knowledge, this is the first case of phloroglucinol-induced AGEP confirmed by reintroduction of the drug.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Acute generalized exanthematous pustulosis; Grossesse; Phloroglucinol; Pregnancy; Pustulose exanthématique aiguë généralisée

Mesh:

Substances:

Year:  2017        PMID: 28242093     DOI: 10.1016/j.annder.2017.01.009

Source DB:  PubMed          Journal:  Ann Dermatol Venereol        ISSN: 0151-9638            Impact factor:   0.777


  1 in total

1.  Efficacy of phloroglucinol for the treatment of pain of gynaecologic or obstetrical origin: a systematic review of literature of randomised controlled trials.

Authors:  Blanchard Clara; Vanderkam Paul; Pouchain Denis; Mignot Stéphanie; Vaillant-Roussel Hélène; Boussageon Rémy
Journal:  Eur J Clin Pharmacol       Date:  2019-08-21       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.